// App-Quantinova.ai

: Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)

Researchers

Presenter

  • Carlos Fernandez

Principal Investigators

  • Christopher M. Rubino

  • Ariel Teper

  • Helen Usansky

  • James D. Chalmers

  • Kevin C. Mange

Medical Centers

  • Ninewells Hospital and Medical School, Dundee, United Kingdom.

  • Institute for Clinical Pharmacodynamics, Inc, Schenectady, United States of America

  • Insmed Incorporated, Bridgewater, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Elaszym

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • II

Study Id's

  • NCT03218917

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved